Medical Device News Magazine

Centinel Spine® Announces First International Use of 3D-Printed Porous Titanium FLX™ Platform

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced the first international implantation of the 3D-Printed Porous Titanium FLX™ platform. Dr. Alfredo Guiroy and Dr. Jose Ricardo Prina in Argentina were the first surgeons outside the United States to implant the STALIF C FLX™ and STALIF M FLX™ devices.

The FLX platform represents the latest material evolution offered by Centinel Spine. The STALIF C FLX and STALIF M FLX devices are 3D-printed porous titanium Integrated Interbody™ implants that have been engineered to mimic bone. These implants provide equivalent subsidence performance to PEEK; contain a proprietary, interconnected FUSE-THRU™ lattice with a structure and modulus of elasticity similar to bone; and have optimized mechanical, visual, and osteophilic environments that reduce stress shielding, enable fusion assessment, and support bony in-growth, on-growth, and thru-growth.

“The STALIF M FLX cage has a bone contact surface much better and larger than any other PEEK cage of the same size and has a maximum capability of osteointegration with the bone,” said Dr. Prina. “We consider that this works much better for a stand-alone procedure.”

“It is my pleasure to use STALIF®. It’s a very good implant, with a lot of versatility due to different sizes and lordotic options, and titanium has shown to be more friendly for fusion than other PEEK/hybrid combinations,” commented Dr. Guiroy.

Centinel Spine’s CEO, Steve Murray, stated, “We are excited to be able to offer our state-of-the-art FLX technology to our international partners. As a company, we remain dedicated to continued innovation and furthering scientific evidence in advancing spine care. We are proud to be able to make our technology available to even more patients on a global scale.”

STALIF M FLX and STALIF C FLX implants are built upon the proven STALIF design, which has over 30 years of clinical history and has helped many patients regain their lives. STALIF implants provide compressive fixation at the fusion site, pulling the vertebral bodies onto the implant and graft material to enhance opportunities for fusion in line with Wolff’s Law of Bone Healing.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”